Cosmetics/Recall·FDA Recalls

Product Recall

HighPublished Apr 9, 2026· AI-analyzed May 4, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

A nail polish remover was recalled following the detection of methylene chloride and chloroform, hazardous substances prohibited for use in cosmetic products.

Who it affects

This affects cosmetic manufacturers, liquid topical product distributors, and quality control labs responsible for testing solvent-based products.

Why it matters

The presence of methylene chloride and chloroform represents a significant regulatory breach, as these substances are strictly prohibited in cosmetics due to toxicity risks. This recall suggests a failure in raw material qualification or manufacturing controls, potentially exposing the manufacturer to heightened FDA scrutiny regarding ingredient safety and Good Manufacturing Practices (GMP). Regulatory teams should consider this a signal that the FDA is actively monitoring for prohibited volatile organic compounds in personal care products.

Practical takeaway

Verify raw material certificates of analysis for solvent purity and implement stringent screening for prohibited substances like methylene chloride in the supply chain for liquid topical formulations. QA teams should perform a retrospective review of existing formulation data to ensure no legacy or unintended hazardous ingredients are present.

FDA source material

Nail Polish Remover recalled due to the detection of methylene chloride and chloroform in the affected product—both hazardous substances that are strictly prohibited in cosmetic formulations.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.